Hyaluronidase as an antidote to extravasation ofVinca alkaloids: Clinical results
- 1 August 1994
- journal article
- clinical trial
- Published by Springer Nature in Zeitschrift für Krebsforschung und Klinische Onkologie
- Vol. 120 (8) , 505-506
- https://doi.org/10.1007/bf01191807
Abstract
Skin necrosis is a recognized potential consequence of an inadvertent extravasation ofVinca alkaloids in the surrounding tissues during i.v. administration. Experimental studies suggest that hyaluronidase, an enzyme that degrades hyaluronic acid and improves the absorption of locally injected drugs, can reduce the risk of progressing to skin necrosis. On this basis, we used this enzyme as a local treatment after extravasations ofVinca alkaloids in seven patients. No patient suffered from subsequent skin necrosis. To the best of our knowledge, this is the first clinical report confirming the positive findings of experimental studies on the effectiveness of this antidote.Keywords
This publication has 4 references indexed in Scilit:
- Antidotes to vesicant chemotherapy extravasationsBlood Reviews, 1990
- Chemotherapy-induced emergencies.1989
- Vinca Alkaloid Skin Toxicity: Antidote and Drug Disposition Studies in the Mouse23JNCI Journal of the National Cancer Institute, 1985
- Clinical uses of hyaluronidase; a current review.1953